← Open Payments lookup

FIDELIA TANYI: Open Payments

NPI 1477104941 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$545 in 25 payments from 12 companies in 2025. Trend: 2023 $240 · 2024 $274 · 2025 $545

Food & beverage: $545
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$93
Lilly USA, LLC4$90
PFIZER INC.4$66
Exact Sciences Corporation3$56
Gilead Sciences, Inc.2$55
Novo Nordisk Inc2$51
ABBVIE INC.1$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26
GlaxoSmithKline, LLC.1$20
Xeris Pharmaceuticals, Inc.1$20

Products named: BREZTRI, MOUNJARO, PREVNAR 20, The Cologuard Plus Collection Kit, VRAYLAR, Ozempic, CAPLYTA, Rybelsus.

Industry payments across MD — which companies pay providers there.